InvestorsHub Logo
Followers 23
Posts 3662
Boards Moderated 0
Alias Born 01/02/2003

Re: None

Monday, 07/29/2019 7:35:55 AM

Monday, July 29, 2019 7:35:55 AM

Post# of 81
Finally an article that makes sense

"inThe Globe and Mail reports in its Saturday, July 27, edition that PI Financial analyst Jason Zandberg says if Canntrust's licensing issue is resolved it "would be the most attractive asset in Canada, given where the stock profile has gone." The Globe's Mark Rendell and Jeffrey Jones write that Mr. Zandberg says, "I'm sure that anyone that's interested in acquiring them would have to sit down with Health Canada and find out what is the likelihood that, under new management, they could continue to operate." Canntrust, which has halted all sales while it deals with its predicament, faces other risks as well, including legal and regulatory ones related to its securities. Canntrust has yet to determine the effect of the situation on its finances, and it is not yet known whether any previous financial results might have to be restated. To date, Health Canada has suspended two pot licences: Ascent Industries and Bonify Medical Cannabis, both for buying from or selling into the black market. In the case of Ascent, after Health Canada announced its intention to suspend its licence, several licensed producers began bidding for its cultivation assets in British Columbia, which were eventually sold to a private company."
Recent TRST News